ExpiresApril 2, 2022
Massachusetts Medical Society
NEJM Knowledge+ Pain Management and Opioids helps clinicians earn mandated CME and learn evidence-based strategies for assessing and managing pain. Available at no cost, it presents best practices for the appropriate use of opioids and strategies for recognizing and treating opioid use disorder. NEJM Knowledge+ features an engaging question bank, written by pain management experts and addiction specialists to reflect the types of clinical cases experienced by health care providers in everyday practice. Pain Management and Opioids covers the entire FDA Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain.
ABMS Member Board Approvals by Type
ABMS MOC Part II Self-Assessment Activity
Physical Medicine and Rehabilitation
ABMS MOC Part II CME Activity
Psychiatry and Neurology
NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
• Choose the most appropriate pain-management strategy for an individual patient.
• Recognize the scenarios in which opioid analgesia is and is not appropriate.
• Recall the importance of routinely assessing pain, function, and adverse effects in patient taking chronic opioid therapy.
• Identify signs of opioid misuse and opioid use disorder.
• Choose the most appropriate strategy for tapering or discontinuing opioid analgesics when necessary.
• Choose the most appropriate intervention when opioid use disorder is suspected.
opioids, pain management, controlled substances, prescribing
Medical Knowledge, Patient Care & Procedural Skills, Practice-based Learning & Improvement, Systems-based Practice
CME Credit Type
AAFP Prescribed Credit, AMA PRA Category 1 Credit
This educational activity is supported by an independent educational grant from the Extended-Release/Long-Acting Opioid Analgesic REMS Program Companies.